Arvee Laboratories (India) logo

ARVEE - Arvee Laboratories (India) Share Price

₹99.2 4.7  5.0%

Last Trade - 20/04/21

Basic Materials
Micro Cap
Market Cap £10.4m
Enterprise Value £12.6m
Revenue £3.28m
Position in Universe th / 3108
Unlock ARVEE Revenue
Relative Strength (%)
1m +146%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High 0.000
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
0.000 34.4 118 129.7 268.2 344.2 +77.8%
-56.3 +728.1
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 September 2017, ArveeLaboratories (India) Ltd revenues totaled RS196.4M. Netincome totaled to RS3.2M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ARVEE Revenue Unlock ARVEE Revenue

Net Income

ARVEE Net Income Unlock ARVEE Revenue

Normalised EPS

ARVEE Normalised EPS Unlock ARVEE Revenue

PE Ratio Range

ARVEE PE Ratio Range Unlock ARVEE Revenue

Dividend Yield Range

ARVEE Dividend Yield Range Unlock ARVEE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ARVEE EPS Forecasts Unlock ARVEE Revenue
Profile Summary

Arvee Laboratories (India) Limited is an India-based company that provides specialty chemical products. The Company is primarily engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. The Company’s Polymer Modifiers includes 5-Sulfoisophthalic Acid Mono Sodium Salt, Dimethyl 5-Sodiosulfoisophthalate and 5-Sulfoisophthalic Acid Mono Lithium Salt. Its Contrast Media Intermediates includes 5-Nitroisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, Monomethyl 5-Nitroisophthalate, 3,5-Diamino Benzoic Acid, Dimethyl 5-Aminoisophthalate and 3,5-Dinitrobenzoic Acid. Its Drug Intermediates includes 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.

Last Annual March 31st, 2017
Last Interim September 30th, 2017
Incorporated January 27, 2012
Public Since February 22, 2018
No. of Shareholders: n/a
No. of Employees: n/a
Sector Basic Materials
Industry Chemicals
Exchange National Stock Exchange of India
Shares in Issue 11,020,000
Free Float (0.0%)
Eligible for
ARVEE Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ARVEE
Upcoming Events for ARVEE
Wednesday 29th September, 2021 Estimate
Arvee Laboratories (India) Ltd Annual Shareholders Meeting
Frequently Asked Questions for Arvee Laboratories (India)
What is the Arvee Laboratories (India) share price?

As of 20/04/21, shares in Arvee Laboratories (India) are trading at ₹99.2, giving the company a market capitalisation of £10.4m. This share price information is delayed by 15 minutes.

How has the Arvee Laboratories (India) share price performed this year?

Shares in Arvee Laboratories (India) are currently trading at ₹99.2 and the price has moved by 0.322k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Arvee Laboratories (India) price has moved by 0.166k% over the past year.

What are the analyst and broker recommendations for Arvee Laboratories (India)?

There are no analysts currently covering Arvee Laboratories (India).

When will Arvee Laboratories (India) next release its financial results?

Arvee Laboratories (India) is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-09-30
What is the Arvee Laboratories (India) dividend yield?

Arvee Laboratories (India) does not currently pay a dividend.

Does Arvee Laboratories (India) pay a dividend?

Arvee Laboratories (India) does not currently pay a dividend.

When does Arvee Laboratories (India) next pay dividends?

Arvee Laboratories (India) does not currently pay a dividend.

How do I buy Arvee Laboratories (India) shares?

To buy shares in Arvee Laboratories (India) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Arvee Laboratories (India)?

Shares in Arvee Laboratories (India) are currently trading at ₹99.2, giving the company a market capitalisation of £10.4m.

Where are Arvee Laboratories (India) shares listed? Where are Arvee Laboratories (India) shares listed?

Here are the trading details for Arvee Laboratories (India):

Country of listing: India
Exchange: NSI
Ticker Symbol: ARVEE
What kind of share is Arvee Laboratories (India)?

We were not able to load our ranking data for Arvee Laboratories (India)

Is there a Arvee Laboratories (India) share price forecast 2021?

We were not able to load any forecast data for Arvee Laboratories (India).

How can I tell whether the Arvee Laboratories (India) share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Arvee Laboratories (India). Over the past six months, the relative strength of its shares against the market has been 97.78%. At the current price of ₹99.2, shares in Arvee Laboratories (India) are trading at 0.168k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Arvee Laboratories (India) PE Ratio?

The Arvee Laboratories (India) PE ratio based on its reported earnings over the past 12 months is 70.45. The shares are currently trading at ₹99.2.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Arvee Laboratories (India)?

Arvee Laboratories (India)'s management team is headed by:

Shalin Patel - MDR
Shalin Chokshi - EDR
Saumil Chokshi - NED
Chandrakala Bhatt - NID
Vishal Mehta - NID
Amishkumar Shah - NID
Maulesh Raval - CFO
Neelam Chotrani - CCO
Who are the major shareholders of Arvee Laboratories (India)?

Here are the top five shareholders of Arvee Laboratories (India) based on the size of their shareholding:

Similar to ARVEE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.